Literature DB >> 11546934

Interferon-alpha generation and immune reconstitution during antiretroviral therapy for human immunodeficiency virus infection.

F P Siegal1, P Fitzgerald-Bocarsly, B K Holland, M Shodell.   

Abstract

OBJECTIVES: To quantify the effect of HIV infection and HIV-suppressive therapy on interferon-alpha (IFN-alpha) production by human blood mononuclear cells; to compare, in parallel, effects on CD4+ T-cell numbers; and to ascertain the relationship of these interferon and CD4 parameters to resistance to opportunistic infections.
DESIGN: Serial studies of 294 unselected patients with HIV infection during therapy, with outcomes analysis.
METHODS: Determination of IFN generation by blood mononuclear cells via bioassay, and T-lymphocyte subset analysis via flow cytometry; serial studies of individual patients; linear regression and chi2 contingency table analysis.
RESULTS: HIV burden is inversely related to interferon-alpha generation, much as it is to CD4+ T-cell counts. Both of these recover during HIV-suppressive therapy. Reconstitution of IFN-alpha generation to levels commensurate with protection against opportunistic infection occurs prior to similar restoration of CD4 counts. In the outcomes analyses, such immune reconstitution was associated with protection from recurrent or new opportunistic infection. Conversely, viral suppression without such immunologic recovery was not protective against opportunistic infection.
CONCLUSIONS: Rapidly responding IFN-alpha generating cells appear to participate in resistance to opportunistic intracellular infection. Recovery of IFN-alpha generation may be an early marker of immune reconstitution in AIDS.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11546934     DOI: 10.1097/00002030-200109070-00002

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  35 in total

Review 1.  The plasmacytoid monocyte/interferon producing cells.

Authors:  Fabio Facchetti; William Vermi; David Mason; Marco Colonna
Journal:  Virchows Arch       Date:  2003-10-28       Impact factor: 4.064

Review 2.  HIV-1 immunopathogenesis: how good interferon turns bad.

Authors:  Jean-Philippe Herbeuval; Gene M Shearer
Journal:  Clin Immunol       Date:  2006-11-16       Impact factor: 3.969

Review 3.  Plasmacytoid dendritic cells: linking innate and adaptive immunity.

Authors:  Kelli McKenna; Anne-Sophie Beignon; Nina Bhardwaj
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

4.  Plasmacytoid dendritic cells reduce HIV production in elite controllers.

Authors:  K Machmach; M Leal; C Gras; P Viciana; M Genebat; E Franco; F Boufassa; O Lambotte; J P Herbeuval; E Ruiz-Mateos
Journal:  J Virol       Date:  2012-02-08       Impact factor: 5.103

5.  An interferon-alpha-induced tethering mechanism inhibits HIV-1 and Ebola virus particle release but is counteracted by the HIV-1 Vpu protein.

Authors:  Stuart J D Neil; Virginie Sandrin; Wesley I Sundquist; Paul D Bieniasz
Journal:  Cell Host Microbe       Date:  2007-09-13       Impact factor: 21.023

6.  Age-dependent changes in peripheral blood dendritic cell subsets in normal children and children with specific polysaccharide antibody deficiency (SPAD).

Authors:  Harumi Jyonouchi; Chongwei Cui; Lee Geng; Zhiwei Yin; Patricia Fitzgerald-Bocarsly
Journal:  Eur J Pediatr       Date:  2010-05-15       Impact factor: 3.183

7.  Spatiotemporal trafficking of HIV in human plasmacytoid dendritic cells defines a persistently IFN-α-producing and partially matured phenotype.

Authors:  Meagan O'Brien; Olivier Manches; Rachel Lubong Sabado; Sonia Jimenez Baranda; Yaming Wang; Isabelle Marie; Linda Rolnitzky; Martin Markowitz; David M Margolis; David Levy; Nina Bhardwaj
Journal:  J Clin Invest       Date:  2011-02-21       Impact factor: 14.808

Review 8.  Current understanding of Pneumocystis immunology.

Authors:  Michelle N Kelly; Judd E Shellito
Journal:  Future Microbiol       Date:  2010-01       Impact factor: 3.165

9.  Persistent virus infection inhibits type I interferon production by plasmacytoid dendritic cells to facilitate opportunistic infections.

Authors:  Elina I Zuniga; Li-Ying Liou; Lauren Mack; Marilyn Mendoza; Michael B A Oldstone
Journal:  Cell Host Microbe       Date:  2008-10-16       Impact factor: 21.023

10.  Human immunodeficiency virus type 1 activates plasmacytoid dendritic cells and concomitantly induces the bystander maturation of myeloid dendritic cells.

Authors:  Jean-François Fonteneau; Marie Larsson; Anne-Sophie Beignon; Kelli McKenna; Ida Dasilva; Ali Amara; Yong-Jun Liu; Jeffrey D Lifson; Dan R Littman; Nina Bhardwaj
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.